• Press Release

Eric J. Nestler, MD, PhD, to Lead Society for Neuroscience

  • New York
  • (July 23, 2015)

Eric J. Nestler, MD, PhD, Nash Family Professor and Chair of the Department of Neuroscience and Director of the Friedman Brain Institute (FBI) at the Icahn School of Medicine at Mount Sinai, has been named president-elect of the Society for Neuroscience, the world’s largest organization of brain and nervous system scientists and physicians, effective at the 2015 annual meeting to be held this fall in Chicago.  The nonprofit organization, founded in 1969, now has nearly 40,000 members in more than 90 countries around the world.

Dr. Nestler’s research focuses on the neurobiological basis of drug addiction and depression.  His laboratory, which is funded by the National Institute on Drug Abuse, National Institute of Mental Health and the Hope for Depression Research Foundation, has pioneered studies to understand, at the molecular level, how drugs of abuse and stress change nerve cells and their brain circuits to cause behavioral abnormalities and to use this knowledge to develop improved treatments.  

“Since Dr. Nestler assumed his current position at Mount Sinai in 2008, he has overseen transformational growth of the neuroscience community under the auspices of The Friedman Brain Institute,” says Kenneth L. Davis, MD, president and chief executive officer of the Mount Sinai Health System.  “We are so pleased that the Society for Neuroscience has recognized his leadership excellence.  I have no doubt that his vision for and commitment to a better understanding of the nervous system will benefit the SFN, as it has for the neurosciences here at Mount Sinai.”

Uniquely, the Friedman Brain Institute integrates all neuroscience efforts throughout Mount Sinai, from basic research in animal and cell models in the Icahn School of Medicine to the delivery of clinical care across the Mount Sinai Health System.  Under Dr. Nestler’s leadership, the neuroscience program has seen an unprecedented scope of growth.  In the past seven years, more than 30 basic neuroscience faculty have been recruited to Mount Sinai, with clinical research and treatment programs experiencing similar expansion.  The FBI’s research and clinical faculty members are national and international leaders, committed to an improved understanding of the nervous system and to real clinical advances in diagnosis and treatment across a broad range of brain and spinal cord disorders.  The Fishberg Department of Neuroscience at Mount Sinai is ranked #3 in the nation for funding from the National Institutes of Health.

Dr. Nestler will assume the presidency at the 2016 annual meeting.

To learn more about the Friedman Brain Institute, please visit:  www.mountsinai.org/fbi


About the Mount Sinai Health System

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report's Best Hospitals, receiving high "Honor Roll" status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children's Hospital among the country’s best in several pediatric specialties. The Icahn School of Medicine at Mount Sinai is one of three medical schools that have earned distinction by multiple indicators: It is consistently ranked in the top 20 by U.S. News & World Report's "Best Medical Schools," aligned with a U.S. News & World Report "Honor Roll" Hospital, and top 20 in the nation for National Institutes of Health funding and top 5 in the nation for numerous basic and clinical research areas. Newsweek’s “The World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York and in the top five globally, and Mount Sinai Morningside in the top 20 globally.

For more information, visit https://www.mountsinai.org or find Mount Sinai on FacebookTwitter and YouTube.